Abstract
No abstract available
Funding Information
  • Novartis
  • National Institutes of Health (1 OT2 OD025276, 1 OT2 OD025277, 1 OT2 OD026555, 1 U24 OD023121, 1 U24 OD023163, 3 OT2 OD023205, 3 OT2 OD023206, AOD 16037, HHSN 263201600085U, U24 OD023176)

This publication has 15 references indexed in Scilit: